EMPOWER-Cervical 1
CEMI vs chemo
L2
Survival with Cemiplimab in Recurrent Cervical Cancer
First author: K.S. Tewari
GOG 240
BEVA+pacl+cis/topo vs pacl+cis/topo
L1
Improved Survival with Bevacizumab in Advanced Cervical Cancer
First author: K.S. Tewari
KEYNOTE 826
PEMB+PCT±BEVA vs PLB+PCT±BEVA
L1
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer